Ro.co vs Maximus: Compare GLP-1 Programs & Pricing
Side-by-side Ro.coand Maximus: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Ro.co and Maximus are telehealth providers that offer GLP-1–based weight management options through clinician-supervised prescriptions. This comparison highlights key differences in pricing, membership requirements, medical oversight, and patient experience so you can make an informed choice.
Ro.co vs Maximus: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Ro.co | Not listed on site | Not listed on site | Brand med access | $145.00 — Yes |
| Maximus | Not listed on site | $132.99 | — No |
Ro.co vs Maximus: Medical Process & Accessibility
Ro.co and Maximus operate under U.S. telehealth regulations: patients complete an online intake, submit medical history, and are evaluated by licensed clinicians before any prescription is issued. Clinicians may request labs, adjust dosing, or decline treatment if GLP-1 therapy is medically inappropriate. This ensures telehealth care aligns with accepted medical standards and FDA labeling considerations.
Ro.co vs Maximus: Pricing Comparison
Both providers publish different elements of their pricing. Ro.co lists a membership requirement and fee of $145.00, which applies to ongoing program access and clinician follow-up. Ro.co’s public site indicates a promotional detail of “Brand med access,” but does not display a standard published starting price for semaglutide or tirzepatide on the page we reviewed — patients are encouraged to confirm current product pricing during intake.
Maximus publishes a starting price for tirzepatide at $132.99, which is shown as the lower listed tirzepatide price in this comparison. Maximus does not require a membership fee, which can reduce upfront costs for some patients. Semaglutide starting prices were not clearly posted on Maximus’s public page; pricing for that medication often varies by pharmacy, dose, and whether a branded product is available.
Ro.co vs Maximus: Clinical Oversight & Support
Both services provide clinician oversight, prescription management, and opportunities for follow-up. Ro.co is built to streamline onboarding and fast approvals for eligible patients, while Maximus emphasizes structured follow-up and dose optimization. In either program, clinicians follow standard safety checks: screening for contraindications, reviewing current medications, and advising on side-effect management.
Book a consultation with Ro.co
Ro.co vs Maximus: Medication Quality & Safety
Medications are typically dispensed through partnered U.S. pharmacies. Note: compounded formulations and pharmacy-supplied generics are not automatically equivalent to FDA-approved branded products such as Wegovy® or Mounjaro®; patients should discuss formulation, storage, and administration with their clinician. All prescribing occurs under medical supervision, and clinicians may modify or stop therapy based on safety concerns.
Learn about Maximus medication options
Ro.co vs Maximus: Customer Experience
User reports indicate Ro.co may appeal to those seeking predictable program fees and a faster path to medication access, while Maximus may be preferred by patients who want no membership fees and close dose-management communication. Shipping times after approval typically range from a few days to about a week, depending on pharmacy processing and location.
Ro.co vs Maximus: Final Verdict
Choose Ro.co if you prioritize an established membership program that bundles clinician follow-up and administrative support. Choose Maximus if you prefer lower upfront program costs (no membership fee) and a published tirzepatide starting price of $132.99. Both providers are licensed telehealth services and screen patients to ensure GLP-1 therapy is safe and appropriate.
Join Ro.co
Get Started with Maximus
Disclaimer
This article is for informational purposes only and does not constitute medical advice. Medication availability, pricing, and program features change frequently. GLP1Talks & GLP1Discussions may receive affiliate commissions at no cost to you. Always consult a licensed clinician to determine whether GLP-1 therapy is appropriate for your medical condition and to discuss FDA-approved options versus compounded alternatives.